MedTrace Logo

Pharmacokinetics of CRD007 in Patients With Abdominal Aorta Aneurisms.

NCT01723618 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2012-11-29

No results posted yet for this study

Summary

The purpose of the study is to determine the plasma levels of CRD007 in patients with abdominal aortic aneurysms after the administration of single doses of tablets containing 10, 25 and 40 mg CRD007.

Conditions

  • Abdominal Aortic Aneurisms

Interventions

DRUG

CRD007

Sponsors & Collaborators

  • RSPR Pharma AB

    lead INDUSTRY

Principal Investigators

  • Nikolaj F Groendal, MD · Department of Vascular Surgery Viborg Hospital Heiberg Allé 4 DK-8800 Viborg Denmark

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01723618 on ClinicalTrials.gov